Document Detail


Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
MedLine Citation:
PMID:  17823524     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We report the case of a 19-year-old woman who developed an acute disseminated pyoderma gangrenosum (PG) during a severe flare of ulcerative colitis (UC). She was successfully treated with a 3-dose regimen of the anti-tumor-necrosis-factor-alpha antibody infliximab. The literature on the effectiveness of this biological agent was reviewed, including 8 other cases of UC-associated PG and 77 cases of Crohn's-disease-associated PG. This case report and the review of the literature demonstrate that infliximab can be successfully used to treat patients with PG associated with inflammatory bowel diseases.
Authors:
Pascal Juillerat; Stephanie Christen-Zäch; François-Xavier Troillet; Suzanne Gallot-Lavallée; Renato G Pannizzon; Pierre Michetti
Related Documents :
3668484 - Primary hyperparathyroidism, hypercalcemia, paranoid delusions, homicide, and attempted...
8503394 - Primary biliary cirrhosis associated with ulcerative colitis.
737424 - An androgen-associated hepatic adenoma in a trans-sexual.
482594 - Pericarditis and inflammatory bowel disease.
20623154 - Colonic perforation following blunt trauma to an inguinal hernia.
1410694 - Acute pesticide morbidity and mortality: california.
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Dermatology (Basel, Switzerland)     Volume:  215     ISSN:  1421-9832     ISO Abbreviation:  Dermatology (Basel)     Publication Date:  2007  
Date Detail:
Created Date:  2007-09-07     Completed Date:  2007-09-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203244     Medline TA:  Dermatology     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  245-51     Citation Subset:  IM    
Copyright Information:
Copyright 2007 S. Karger AG, Basel.
Affiliation:
Division of Gastroenterology and Hepatology, University of Lausanne, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antibodies, Monoclonal / therapeutic use*
Colitis, Ulcerative / complications*
Dermatologic Agents / therapeutic use*
Female
Humans
Pyoderma Gangrenosum / drug therapy*,  etiology
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Dermatologic Agents; 0/infliximab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thalidomide in the treatment of Kaposi's sarcoma.
Next Document:  Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD2...